Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Participants will receive nicotine replacement therapy, counseling, and and complete questionnaires. We hypothesize that integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) can improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Participants interested in quitting tobacco will be offered standard tobacco cessation care including nicotine replacement therapy and counseling.
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, United States
Biochemically confirmed abstinence
We will measure the biochemically-confirmed self-reported smoking cessation rate at 13 weeks post-enrollment (a cessation rate of ≥ 15-20% will be a sign of feasibility).
Time frame: 13 weeks post enrollment
Rate of enrollment
We will measure the rate of enrollment over those approached to be in the study (≥ 25% enrolled will indicate feasibility).
Time frame: Duration of the study (approximately 6 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.